A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/505 (2006.01) A61K 31/435 (2006.01) A61K 31/437 (2006.01) A61K 31/44 (2006.01) A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01)
Patent
CA 2189830
Disclosed is a pharmaceutical composition for treating, preventing or inhibiting cardiovascular or heart related diseases, comprising (a) a compound of the formula Image or Image I II or a pharmaceutically acceptable salt thereof, wherein A is N or CR7 (in which R7 is H, alkyl, halo or the like), B is -NR1R2, -CR1 R2R11 or the like (in which R1 is H or alkyl, R2 is alkyl, aryl, arylalkyl, cycloalkyl or the like and R11 is H, OH or the like), D is N, -CR10 (in which R10 is H, alkyl, halo or the like ), C=O, -C=NH, etc.), E is -CR4 (in which R4 is H, alkyl, halo etc.), N, -NR6 or -CR4R6 (in which R4 is H, alkyl, halo, etc. and R6 is H or alkyl), Y is N or CH, Z is O, S, NH, ect., R3 is H, alkyl, halo, etc., R4 is H, alkyl, halo, etc. and R5 is a cyclic group, and (b) a pharmaceutically acceptable diluent or carrier.
Chen Yuhpyng Liang
Fossa Anthony Andrea
Limited Pfizer
Smart & Biggar
LandOfFree
Uses for corticotropin releasing factor atagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses for corticotropin releasing factor atagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for corticotropin releasing factor atagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2035774